Skip to main content
Clinical Trials/NCT03773913
NCT03773913
Unknown
N/A

Integrated Community Based Health Systems Strengthening in Northern Togo: A Preliminary Mixed-Methods Study in Kozah District

Integrate Health1 site in 1 country1,500 target enrollmentJanuary 1, 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Maternal-Child Health Services
Sponsor
Integrate Health
Enrollment
1500
Locations
1
Primary Endpoint
Under-five year old mortality rate, annual
Last Updated
6 years ago

Overview

Brief Summary

This preliminary study aims to inform the design and delivery of the integrated facility and community-based health systems strengthening (ICBHSS) model in four Kozah District health facilities over a period of 48 months. Specific aims include: (1) Assess maternal and child health outcomes and health service utilization rates in the 4 ICBHSS model intervention sites catchment areas; (2) Identify barriers to and facilitators of access and quality services related to ICBHSS model; and (3) Assess changes in health care services coverage, effectiveness, and adoption of ICBHSS model.

Detailed Description

Intervention: The investigators have adapted an integrated facility and community-based health systems strengthening (ICBHSS) model to improve primary healthcare services in Togo. The ICBHSS model includes a bundle of evidence based interventions including (1) community engagement meetings and feedback; (2) the elimination of facility user fees for children under five and pregnant women; (3) pro-active community based IMCI using Community Health Workers (CHWs) with additional services including linkage to family planning and counseling, HIV testing \& referrals; (4) clinical mentoring and enhanced supervision at public sector facilities; and (5) improved supply chain management and facility structures. Study: The investigators will conduct a mixed methods assessment, using the RE-AIM framework to evaluate the impact and implementation of the ICBHSS initiative in Kozah district. It will include: (1) a repeated cross-sectional study to obtain annual coverage, effectiveness, and adoption metrics using a population-based household survey as well as (2) qualitative key informant interviews and focus group discussions conducted at 12 months for each intervention health facility. The primary outcome will be under 5 year old mortality rate, with secondary outcomes including under-one mortality rate, maternal mortality rate, as well as maternal and child health service utilization.

Registry
clinicaltrials.gov
Start Date
January 1, 2015
End Date
August 31, 2021
Last Updated
6 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Integrate Health
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Female of reproductive age (aged 15-49 years)
  • Individuals aged 15-17 years will only be included if they have children and/or are pregnant
  • Lives in selected household within study catchment area
  • Informed consent is obtained for participants 18-49
  • Waiver of parental permission is obtained for 15-17 year-old participants

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Under-five year old mortality rate, annual

Time Frame: 72 months

The under-five mortality rate (expressed as a rate per 1,000 live births) is the probability of a child dying in a specified year between birth and 5 years of age.

Secondary Outcomes

  • Maternal mortality rate, annual(72 months)
  • Maternal facility based birth delivery incidence rate, annual(72 months)
  • Protocol adherence by clinical staff at IH intervention facilities in iCCM and maternal consultations(72 months)
  • Annual proportion of children under age five reported to have a cough in the prior two weeks who received an effective pneumonia treatment within 24 hours of symptom onset.(72 months)
  • Protocol Adherence by IH community health workers in iCCM and maternal consultations(72 months)
  • Under-one year old mortality rate, annual(72 months)
  • Annual proportion of children under age five reported to be febrile in the prior two weeks who received an effective antimalarial treatment within 24 hours of symptom onset.(72 months)
  • Annual proportion of children under age five reported to have diarrhea in the prior two weeks who received an effective treatment for diarrheal disease within 24 hours of symptom onset.(72 months)

Study Sites (1)

Loading locations...

Similar Trials